Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07647679 · ClinicalTrials.gov registry record · NA
Lattice Radiotherapy for Adults With Large Tumors
A NA study, sponsored by Duke University.
- Not yet
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT07647679 is a NA study that has not yet begun recruiting, run by Duke University. The registered enrollment target is 25 participants.
The verdict
NCT07647679, a NA study, has not yet begun recruiting, sponsored by Duke University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
The purpose of this study is to ask whether using a specialized radiation therapy technique called Lattice Radiation Therapy (LRT) can shrink large tumors when given with palliative radiation therapy. The primary questions are: * if LRT is safe and does not worsen existing side effects or cause new side effects * if adding LRT to standard radiation therapy can improve tumor shrinkage. Participants will have one additional radiation treatment (LRT) prior to starting palliative radiation and then their progress will be followed for one year.
Interventions
- RADIATION Lattice Radiation Therapy (LRT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2026-08-01 |
| Est. Completion | 2030-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07647679
The ClinicalTrials.gov registry entry for NCT07647679 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lattice Radiation Therapy (LRT) is the first listed.
NCT07647679 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07647679 about?
NCT07647679 is a clinical study titled "Lattice Radiotherapy for Adults With Large Tumors". The purpose of this study is to ask whether using a specialized radiation therapy technique called Lattice Radiation Therapy (LRT) can shrink large tumors when given with palliative radiation therapy. The primary questions are: * if LRT is safe and does not worsen existing side effects or cause new...
What is the current status of trial NCT07647679?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2026-08-01. Estimated completion is 2030-08.
What interventions are being tested in trial NCT07647679?
The interventions under investigation include: Lattice Radiation Therapy (LRT) (RADIATION).
Who is sponsoring clinical trial NCT07647679?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.